Macmillan invests in Lucida Medical’s AI prostate cancer diagnostic aid
Macmillan Cancer Support is investing £350,100 in Lucida Medical’s new AI platform, Pi, with the aim of improving the speed and accuracy
Macmillan Cancer Support is investing £350,100 in Lucida Medical’s new AI platform, Pi, with the aim of improving the speed and accuracy